I do seem to recall Ohm having that opinion, and I

I do seem to recall Ohm having that opinion, and I also agree with it. But regardless, as long as the additional benefits of using LL occur, you'd see a greater effect using LL with Keytruda versus just Keytruda alone. I don't care if Keytruda, a multi-billion dollar juggernaut, gets to share in the "blame". They've got a Respert-like status in the world of pharma, so if we can hitch our wagon to them I have no problem with it. Even if in the end we're actually shouldering the load.

#HeSaidLoad